| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Jan―22 |
Engineering Elastin-Like Peptide-Based Nanoparticles displaying Variable Domain of the Heavy Chain of Heavy-Chain-Only Antibodies for SARS-CoV-2 Neutralization |
Duc H. T. Le, Jenny van Oostrum, Els van de Westerlo, Jianhong Wang, Gijs J. Overheul, Ronald P. van Rij, et al. (+5) William P. J. Leenders, Jetta Bijlsma, Ilse Roodink, Jan C. M. van Hest, Wouter P.R. Verdurmen |
| 2 |
[GO] |
2025―Sep―08 |
Engineering a Coiled-Coil Protein for DARPin Presentation as a Potent SARS-CoV-2 Therapeutic |
Linh D. Mai, Narayanaiah Cheedarla, Siamalan Krishnathas, Ishmamul H. Sadab, Mikaela A. Gray, Wei Lv, et al. (+4) Anshul Dhankher, John D. Roback, Andrew S. Neish, Julie A. Champion |
| 3 |
[GO] |
2025―Jul―07 |
Controlling the Sulfation Density of Glycosaminoglycan Glycopolymer Mimetics Enables High Antiviral Activity against SARS-CoV-2 and Reduces Anticoagulant Activity |
Miriam Hoffmann, Lorand Bonda, Ines Fels, Darisuran Anhlan, Eike Hrincius, Derik Hermsen, et al. (+4) Stephan Ludwig, Mario Schelhaas, Nicole L. Snyder, Laura Hartmann |
| 4 |
[GO] |
2025―May―07 |
Structural Basis of SARS-CoV-2 Nsp13-Derived Peptide-Mediated NK Cell Activation |
Xiaole Xu, Song Luo, Jinxin Liu, Enhao Zhang, Houde Liang, Lili Duan |
| 5 |
[GO] |
2023―Mar―31 |
Biomimetic SARS-CoV-2 Spike Protein Nanoparticles |
Alvin Phan, Hugo Avila, J. Andrew MacKay |
| 6 |
[GO] |
2022―Dec―23 |
Dendrimer-Peptide Conjugates for Effective Blockade of the Interactions between SARS-CoV-2 Spike Protein and Human ACE2 Receptor |
Woo-jin Jeong, Jiyoon Bu, Philip Mickel, Yanxiao Han, Piper A Rawding, Jianxin Wang, et al. (+4) Hanbit Kang, Heejoo Hong, Petr Král, Seungpyo Hong |
| 7 |
[GO] |
2022―Aug―22 |
Surface Inactivation of Highly Mutated SARS-CoV-2 Variants of Concern: Alpha, Delta, and Omicron |
Valentin A. Bobrin, Sung-Po R. Chen, Carlos Fitzgerald Grandes Reyes, Tim Smith, Damian F. J. Purcell, Jason Armstrong, et al. (+2) Julie L. McAuley, Michael J. Monteiro |
| 8 |
[GO] |
2022―Aug―03 |
PEDOT:PSS in Solution Form Exhibits Strong Potential in Inhibiting SARS-CoV-2 Infection of the Host Cells by Targeting Viruses and Also the Host Cells |
Jo-Ning Hung, Di Ngoc Kha Vo, Ha Phan Thanh Ho, Ming-Han Tsai |
| 9 |
[GO] |
2022―Mar―28 |
Injectable Slow-Release Hydrogel Formulation of a Plant Virus-Based COVID-19 Vaccine Candidate |
Christian Isalomboto Nkanga, Oscar A. Ortega-Rivera, Matthew D. Shin, Miguel A. Moreno-Gonzalez, Nicole F. Steinmetz |
| 10 |
[GO] |
2022―Jan―26 |
Inhalable SARS-CoV-2 Mimetic Particles Induce Pleiotropic Antigen Presentation |
Atip Lawanprasert, Andrew W. Simonson, Sarah E. Sumner, McKayla J. Nicol, Sopida Pimcharoen, Girish S. Kirimanjeswara, Scott H. Medina |
| 11 |
[GO] |
2021―Dec―09 |
Lysine β-Hydroxybutyrylation Improves Stability of COVID-19 Antibody |
Zihua Li, Yudian Zhang, Meng Han, Haiteng Deng, Fuqing Wu, Gang Liu, Guo-Qiang Chen |
| 12 |
[GO] |
2021―Sep―07 |
Blending of Designer Synthetic Polymers to a Dual Targeted Nanoformulation for SARS-CoV-2 Associated Kidney Damage |
Bapurao Surnar, Anuj S. Shah, Subham Guin, Nagesh Kolishetti, Alessia Fornoni, Shanta Dhar |
| 13 |
[GO] |
2021―Feb―05 |
Virus-Like Particles as Positive Controls for COVID-19 RT-LAMP Diagnostic Assays |
Soo Khim Chan, Pinyi Du, Caroline Ignacio, Sanjay Mehta, Isabel G. Newton, Nicole F. Steinmetz |
|
